{"gene":"FOXP4","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":2002,"finding":"FOXP4 is a member of the Foxp subfamily of winged-helix (forkhead) transcription factors, encoding a 685-amino-acid protein similar to FOXP1 and FOXP2, expressed primarily in pulmonary epithelium (proximal and distal airway), neural tissues, and gut epithelial cells during embryonic development, as determined by immunohistochemical analysis with specific polyclonal antisera.","method":"Immunohistochemistry with specific polyclonal antisera; in situ hybridization; cDNA characterization","journal":"Mechanisms of development / Gene expression patterns","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein localization by IHC with specific antisera and parallel in situ hybridization, replicated across two publications from same group","pmids":["14516685","12617805"],"is_preprint":false},{"year":2014,"finding":"FOXP4 forms homo- and heterodimers with FOXP1 and FOXP2, and specific combinations of FOXP1/2/4 dimers differentially regulate transcription of known FOXP2 target genes (including CER1, SFRP4, WISP2, PRICKLE1, NCOR2, SNW1, NEUROD2, PAX3, EFNB3, and SLIT1) involved in early neuronal development, as shown by stable transfection of open-reading frames into HEK293 cells and quantitative real-time PCR.","method":"Stable transfection of FOXP1/2/4 ORFs in HEK293 cells; qRT-PCR of target gene expression","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — cell-based overexpression with qRT-PCR readout, single lab, single method but covers multiple targets and dimer combinations","pmids":["25027557"],"is_preprint":false},{"year":2010,"finding":"Foxp4 is expressed specifically in migrating and mature Purkinje cells of the cerebellum and is required for the maintenance (but not initiation) of Purkinje cell dendritic arborization; siRNA-mediated knockdown at postnatal day 10 in organotypic cerebellar slice cultures caused highly impaired dendritic arbor organization and loss of associated Bergmann glial fiber radial alignment, without inducing apoptosis.","method":"siRNA knockdown in organotypic cerebellar slice culture; morphological analysis of dendritic arbors","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in organotypic tissue model with defined cellular phenotype, single lab","pmids":["20951773"],"is_preprint":false},{"year":2012,"finding":"Foxp4 is expressed in thymocytes and peripheral CD4+ and CD8+ T cells, increases following T cell activation, and is dispensable for T cell development, Foxp3+ Treg generation, and in vitro proliferative/effector responses; however, Foxp4-deficient CD4 T cells show reduced effector cytokine production during antigen-specific recall responses in vivo (Toxoplasma gondii and LCMV infection models), as assessed by CD4Cre-mediated conditional knockout.","method":"CD4Cre conditional knockout; flow cytometry; in vivo infection challenge with T. gondii and LCMV; cytokine measurement","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean conditional KO with defined in vivo phenotypic readout, single lab, multiple infection models","pmids":["22912696"],"is_preprint":false},{"year":2015,"finding":"Combined conditional knockout of FOXP1, FOXP2, and FOXP4 (but not individual knockouts) in pancreatic islet endocrine cells (using Pax6-Cre) causes hypoglycemia and hypoglucagonemia due to reduced alpha cell mass and impaired glucagon secretion; this is mediated through effects on cell cycle mediators (decreased Ccna2, Ccnb1, Ccnd2; increased Cdkn1a), while beta cell insulin secretion remains intact.","method":"Triple conditional knockout (Pax6-Cre) mice; glucose tolerance testing; radioimmunoassay; immunohistochemistry; gene expression in isolated islets; glucose-stimulated hormone secretion assays","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 2 / Strong — well-controlled genetic loss-of-function with multiple orthogonal physiological and molecular readouts, epistasis analysis with single and compound KOs","pmids":["26021489"],"is_preprint":false},{"year":2019,"finding":"FOXP4 transcriptionally regulates Slug (SNAI2), an EMT-associated transcription factor, to promote EMT in hepatocellular carcinoma cells; this was established by ChIP, qChIP, and luciferase reporter assays showing FOXP4 binding to the Slug promoter, and gain/loss-of-function experiments demonstrating FOXP4 controls migration and invasion through this mechanism.","method":"ChIP and qChIP assays; luciferase reporter assay; gain- and loss-of-function experiments in HCC cell lines","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding confirmed by ChIP plus functional validation by luciferase, single lab","pmids":["30930991"],"is_preprint":false},{"year":2019,"finding":"FOXP4 transcriptionally activates Snail (SNAI1) in breast cancer cells by binding to the Snail promoter (confirmed by ChIP, qChIP, and dual luciferase reporter assays), promoting EMT; overexpression of Snail partially rescued the inhibitory effect of FOXP4 knockdown on migration and invasion.","method":"ChIP assay; dual luciferase reporter assay; gain- and loss-of-function experiments","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter binding confirmed by ChIP plus luciferase, single lab","pmids":["31040716"],"is_preprint":false},{"year":2019,"finding":"Lentiviral knockdown of FoxP4 in Area X (striatal song nucleus) of juvenile male zebra finches impaired vocal production learning, with song deficits partly overlapping but distinct from those caused by FoxP1 or FoxP2 knockdown, indicating non-redundant but partially shared roles of FoxP1/2/4 in Area X-dependent vocal learning.","method":"Lentivirus-mediated knockdown in Area X of juvenile zebra finches; song analysis (spectral and temporal features); comparison across FoxP1/2/4 knockdown groups","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vivo loss-of-function with quantified behavioral readout, multiple FoxP comparisons, single lab","pmids":["31641053"],"is_preprint":false},{"year":2020,"finding":"Heterozygous missense variants in the FOXP4 forkhead box DNA-binding domain cause loss of transcriptional repressor activity (demonstrated by luciferase assays) and in some cases aberrant subcellular localization, leading to an autosomal dominant neurodevelopmental disorder with speech/language delays, growth abnormalities, congenital diaphragmatic hernia, cervical spine abnormalities, and ptosis.","method":"Luciferase transcriptional repressor assays; subcellular localization assays; clinical phenotyping of 8 individuals with de novo FOXP4 variants","journal":"Genetics in medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal functional assays (luciferase + localization) across multiple independent patient variants, establishes loss-of-function mechanism","pmids":["33110267"],"is_preprint":false},{"year":2021,"finding":"FOXP4 directly activates UCP1 transcription in thermogenic adipocytes, as demonstrated by chromatin immunoprecipitation and luciferase assays; FoxP4 is induced by heat shock factor protein 1 (HSF1) via a heat shock response element in the FoxP4 proximal promoter, and gain/loss-of-function studies show FoxP4 regulates multiple brown and beige fat genes and affects oxygen consumption in isolated adipocytes.","method":"Chromatin immunoprecipitation (ChIP); luciferase reporter assay; gain- and loss-of-function in adipocytes; oxygen consumption assay; in vivo thermogenic stimulation","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct ChIP and luciferase evidence for UCP1 regulation and HSF1-mediated induction, single lab with multiple orthogonal methods","pmids":["34384787"],"is_preprint":false},{"year":2022,"finding":"FOXP4 deficiency in beige adipocyte progenitors impairs early beige cell differentiation, whereas ablation of Foxp4 in differentiated adipocytes potentiates thermogenesis capacity upon cold exposure by de-repressing the thermogenic program; this effect is specific to beige adipocytes and not brown adipocytes, establishing FOXP4 as a transcriptional repressor of the beige thermogenic program in differentiated cells.","method":"Beige adipocyte-specific conditional knockout mice; cold exposure experiments; gene expression analysis","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO mouse models at two different cell stages with defined functional phenotype, single lab","pmids":["35297993"],"is_preprint":false},{"year":2022,"finding":"FOXP4 promotes proliferation and inhibits squamous differentiation of atypical cervical cells via an ELF3-dependent pathway; FOXP4 knockdown in W12 (HPV16+) cells attenuated proliferation and induced squamous differentiation in monolayer and organotypic raft cultures through regulation of ELF3.","method":"FOXP4 siRNA knockdown in W12 cells; monolayer and organotypic raft culture; proliferation assays; gene expression analysis; ELF3 pathway analysis","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in two culture systems with defined differentiation phenotype and pathway placement via ELF3, single lab","pmids":["35838233"],"is_preprint":false},{"year":2022,"finding":"FOXP1 and FOXP4 form a complex in vivo in hair follicle cells; combined (but not individual) conditional knockout of Foxp1/4 in hair follicles causes additive defects including precocious HFSC activation, hair cycling acceleration, hair loss, downregulation of Fgf18 and Bmp6 in bulge cells, and apoptosis of K6+ inner bulge cells (the stem cell niche), leading to destruction of the niche.","method":"Co-immunoprecipitation (complex formation in vitro and in vivo); hair follicle-specific conditional knockout mice (single and double KO); immunofluorescence; apoptosis assays; gene expression","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal complex formation plus genetic epistasis via double KO with defined niche phenotype, single lab","pmids":["35759955"],"is_preprint":false},{"year":2023,"finding":"FOXP4 knockdown or dominant-negative inhibition in the mouse neocortex abolishes apical condensation of N-cadherin in radial glial cells (RGCs), disrupts adherens junction integrity in the ventricular zone, impedes radial migration of cortical neurons, and causes ectopic neurogenesis; N-cadherin overexpression in RGCs rescues the migration and differentiation defects, placing FOXP4 upstream of N-cadherin-based adherens junctions in cortical development.","method":"In utero shRNA knockdown and dominant-negative inhibition; N-cadherin overexpression rescue; immunofluorescence; cortical neuron migration analysis in mice","journal":"Neuroscience bulletin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with genetic rescue experiment establishing epistatic relationship, single lab","pmids":["36646976"],"is_preprint":false},{"year":2023,"finding":"FOXP4 promotes proliferation of human spermatogonial stem cells (SSCs); conditional inactivation of FOXP4 in human SSC lines suppressed proliferation and significantly activated apoptosis, and FOXP4 expression was found to specifically mark a subset of spermatogonia with stem cell potential.","method":"Conditional inactivation in human SSC lines; single-cell RNA sequencing analysis; proliferation and apoptosis assays","journal":"Asian journal of andrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in human SSC lines with defined proliferation/apoptosis phenotype, supported by single-cell expression data, single lab","pmids":["36018067"],"is_preprint":false},{"year":2024,"finding":"FOXP4 directly induces PTK7 (a Wnt co-receptor) transcription in ovarian cancer, thereby activating the Wnt/β-catenin signaling pathway and promoting malignant phenotype; RNA sequencing in FOXP4-deficient cells identified PTK7 as a downstream target, and restoration of PTK7 reversed the effects of FOXP4 loss.","method":"RNA sequencing in FOXP4-deficient cells; ChIP or functional promoter assays (inferred from 'directly induces'); PTK7 rescue experiments; Wnt pathway activity assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-seq plus genetic rescue establishing pathway hierarchy, single lab; direct binding evidence implied but not explicitly detailed in abstract","pmids":["38740744"],"is_preprint":false},{"year":2024,"finding":"FOXP4 is a direct transcriptional target of YAP1 in gastric cancer; FOXP4 upregulation by YAP1 maintains cancer stemness by transcriptionally activating SOX12; FOXP4 loss impairs spheroid formation and stemness marker expression, while a small-molecule screen identified 42-(2-tetrazolyl) rapamycin as a FOXP4 inhibitor.","method":"RNA sequencing; functional loss-of-function (spheroid, stemness markers); small-molecule inhibitor screen; ChIP or transcriptional assays for YAP1→FOXP4 and FOXP4→SOX12; in vivo xenograft","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-seq plus functional and pharmacological validation, multiple downstream targets, single lab","pmids":["39047223"],"is_preprint":false},{"year":2024,"finding":"FOXP4 promotes radioresistance in colorectal cancer by transcriptionally activating GPX4 (glutathione peroxidase 4) via binding to the GPX4 promoter through its forkhead domain, thereby suppressing ferroptosis; doxorubicin promotes FOXP4 ubiquitination and degradation, reducing GPX4 expression and increasing radiosensitivity.","method":"Patient-derived organoids (PDOs); transcriptome analysis; ChIP/CUT&Tag for FOXP4 binding to GPX4 promoter; ubiquitination assay; clonogenic and xenograft assays","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding by CUT&Tag plus functional ferroptosis and ubiquitination assays, single lab with PDO model","pmids":["40789053"],"is_preprint":false},{"year":2021,"finding":"FOXP4 transcriptionally activates β-catenin (CTNNB1) expression in esophageal squamous cell carcinoma cells, thereby promoting Wnt/β-catenin signaling and malignant progression; this was established by luciferase reporter assay showing FOXP4 drives β-catenin transcription.","method":"Luciferase reporter assay; shRNA knockdown; gene expression analysis; RIP and ChIP (for FOXP4-AS1 mechanism upstream)","journal":"Frontiers in oncology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — luciferase assay for FOXP4→β-catenin, single lab, single method for this specific mechanistic claim","pmids":["34970490"],"is_preprint":false},{"year":2021,"finding":"FOXP4 directly binds the promoter of LEF-1 and activates Wnt signaling in laryngeal squamous cell carcinoma, as confirmed by chromatin immunoprecipitation and luciferase reporter assays; FOXP4 also participates in EMT regulation in this cancer type.","method":"ChIP assay; luciferase reporter assay; gain- and loss-of-function experiments; microarray for differential transcript identification","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter binding confirmed by ChIP plus luciferase, single lab","pmids":["34590150"],"is_preprint":false},{"year":2024,"finding":"FOXP4 transcriptionally represses FBXW7 (a tumor suppressor) in thyroid cancer cells; FOXP4 protein binding to the FBXW7 promoter was confirmed by ChIP assay, and FBXW7 overexpression reversed the effects of FOXP4-driven proliferation, migration, and EMT.","method":"ChIP assay; luciferase reporter; gain- and loss-of-function; xenograft","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter binding by ChIP with functional rescue experiment, single lab","pmids":["38293397"],"is_preprint":false},{"year":2024,"finding":"FOXP4 transcriptionally activates NDST2 in hepatocellular carcinoma cells after incomplete thermal ablation (heat stress), as validated by CUT&Tag experiments showing FOXP4 binding to NDST2 regulatory regions; suppression of FOXP4 reduced NDST2 expression and weakened cancer cell progression.","method":"CUT&Tag; qRT-PCR; Western blotting; CCK-8, scratch, Transwell assays","journal":"Journal of hepatocellular carcinoma","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromatin binding by CUT&Tag with functional loss-of-function, single lab","pmids":["39429915"],"is_preprint":false},{"year":2025,"finding":"Combined but not individual deficiency of FOXP1 and FOXP4 in FOXP3+ committed Tregs causes lymphoproliferation, inflammation, autoimmunity, and early lethality; loss of both proteins results in an activated/effector phenotype with compromised Treg suppressive function, enhanced germinal center response, and proinflammatory cytokine production; FOXP1 and FOXP4 both bind to Il2ra (CD25) promoter regions to regulate CD25 expression, as demonstrated by promoter-binding assays.","method":"Foxp3-Cre conditional knockout of Foxp1, Foxp4, or both; flow cytometry; cytokine assays; promoter-binding assays for Il2ra; immune phenotyping","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous triple genetic comparison (single and double KO) with multiple orthogonal functional readouts and direct promoter binding evidence","pmids":["40794436"],"is_preprint":false},{"year":2024,"finding":"An enhancer variant (rs10223516) in FOXP4 modulates FOXP4 expression through long-range chromatin interaction; the T allele shows higher enhancer activity; upregulated FOXP4 promotes ESCC development in vivo; ChIP-seq and RNA-seq revealed FOXP4 transcriptionally activates CYP26B1 and MYC in ESCC cells.","method":"Three-stage case-control GWAS; functional enhancer assay; in vivo ESCC model; ChIP-seq; RNA-seq","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enhancer activity assay plus ChIP-seq for direct transcriptional targets, supported by large genetic study, single lab","pmids":["40228145"],"is_preprint":false},{"year":2024,"finding":"METTL14-induced N6-methyladenosine (m6A) modification of FOXP4 mRNA in HBV-infected hepatocellular carcinoma cells enhances FOXP4 mRNA stability and increases FOXP4 mRNA levels; HBV gene expression activates the PI3K/AKT pathway via modulation of FOXP4 mRNA stability.","method":"m6A modification analysis; mRNA stability assays; PI3K/AKT pathway analysis; HBV infection model","journal":"Journal of Cancer","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mRNA modification and stability assays described in abstract without full mechanistic detail, single lab, single study","pmids":["39513116"],"is_preprint":false},{"year":2024,"finding":"FOXP4 is highly expressed in anterior segment structures relevant to the drainage angle (periocular mesenchyme, iris, ciliary body, cornea) in embryonic mouse eyes; a FOXP4 missense variant (p.Q478R) in the forkhead domain acts as a hypomorphic allele retaining transcriptional activity but frequently mislocalizing to cytosolic aggregates, suggesting protein instability underlies pathogenicity in angle closure glaucoma.","method":"Exome sequencing; immunostaining in embryonic mouse eyes; YFP-tagged mutant/WT protein expression in HEK-293T and ARPE-19 cells for nuclear localization; SRPX2-luciferase reporter for transcriptional activity","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell-based functional assays (localization + transcriptional reporter) plus in vivo expression data, single lab","pmids":["40637512"],"is_preprint":false}],"current_model":"FOXP4 is a forkhead box transcription factor that functions as a transcriptional activator or repressor depending on cellular context; it homo- and heterodimerizes with FOXP1 and FOXP2 to differentially regulate target gene expression, directly binds promoters of downstream targets including UCP1, GPX4, Slug/Snail, LEF-1, PTK7, SOX12, FBXW7, NDST2, CYP26B1, MYC, and CD25 (Il2ra), and plays essential developmental roles in lung/gut epithelium, Purkinje cell dendritic maintenance, cortical neuron migration (via N-cadherin adherens junctions), alpha cell proliferation and glucagon secretion, thermogenic adipocyte differentiation and activation, hair follicle stem cell niche maintenance (redundantly with FOXP1), and T cell cytokine recall responses; heterozygous loss-of-function variants in its forkhead DNA-binding domain cause an autosomal dominant neurodevelopmental disorder with speech/language delays and congenital abnormalities."},"narrative":{"mechanistic_narrative":"FOXP4 is a forkhead/winged-helix transcription factor of the FOXP subfamily that acts as a context-dependent activator or repressor to control epithelial, neuronal, immune, metabolic, and stem-cell programs during development [PMID:14516685, PMID:12617805, PMID:25027557]. It assembles into homo- and heterodimers with FOXP1 and FOXP2, and distinct dimer combinations differentially tune shared neuronal target genes, establishing combinatorial FOXP coding as a core regulatory logic [PMID:25027557]. This combinatorial principle recurs across tissues through genetic redundancy: only compound loss of FOXP1/2/4 in pancreatic islet endocrine cells reduces alpha-cell mass and glucagon secretion via cell-cycle mediators [PMID:26021489], compound FOXP1/4 loss in hair follicles destroys the stem-cell niche [PMID:35759955], and combined FOXP1/4 deletion in Tregs causes autoimmunity, with both factors binding the Il2ra (CD25) promoter [PMID:40794436]. FOXP4 directly binds target promoters through its forkhead DNA-binding domain to drive distinct programs: it activates the thermogenic gene UCP1 in adipocytes downstream of HSF1 while acting as a repressor of the beige thermogenic program in differentiated cells [PMID:34384787, PMID:35297993], and it controls cortical neuron migration by maintaining N-cadherin-based adherens junctions in radial glia [PMID:36646976]. In cancer it functions as a pro-malignant transcription factor, directly regulating EMT effectors Slug and Snail, Wnt-pathway components LEF-1 and PTK7, and additional targets including GPX4 (suppressing ferroptosis), SOX12, FBXW7, NDST2, CYP26B1, and MYC [PMID:30930991, PMID:31040716, PMID:38740744, PMID:40789053]. Heterozygous missense variants in the FOXP4 forkhead domain abolish transcriptional repressor activity and can mislocalize the protein, causing an autosomal dominant neurodevelopmental disorder with speech/language delay and congenital abnormalities [PMID:33110267].","teleology":[{"year":2002,"claim":"Establishing FOXP4 as a forkhead transcription factor and mapping its developmental expression defined where in the embryo it might act.","evidence":"cDNA characterization, IHC with specific antisera, and in situ hybridization across embryonic tissues","pmids":["14516685","12617805"],"confidence":"Medium","gaps":["No direct target genes identified at this stage","No functional loss-of-function data"]},{"year":2010,"claim":"Showed FOXP4 has a tissue-specific maintenance role, being required to sustain Purkinje cell dendritic arborization rather than to initiate it.","evidence":"siRNA knockdown in organotypic cerebellar slice culture with dendritic morphology analysis","pmids":["20951773"],"confidence":"Medium","gaps":["Direct transcriptional targets in Purkinje cells not identified","Mechanism linking FOXP4 to Bergmann glial alignment unresolved"]},{"year":2012,"claim":"Defined a non-essential but modulatory immune role, with FOXP4 dispensable for T cell development but required for full effector cytokine recall responses.","evidence":"CD4Cre conditional knockout with in vivo T. gondii and LCMV challenge and cytokine measurement","pmids":["22912696"],"confidence":"Medium","gaps":["Target genes controlling cytokine recall not identified","Possible redundancy with other FOXPs not tested here"]},{"year":2014,"claim":"Established the combinatorial logic of FOXP regulation by showing FOXP4 dimerizes with FOXP1/2 and that specific dimers differentially regulate shared targets.","evidence":"Stable transfection of FOXP1/2/4 ORFs in HEK293 cells with qRT-PCR of target genes","pmids":["25027557"],"confidence":"Medium","gaps":["Overexpression system may not reflect endogenous stoichiometry","Direct DNA binding by FOXP4 not shown in this study"]},{"year":2015,"claim":"Demonstrated functional redundancy among FOXP1/2/4 in vivo, where only compound deletion impairs alpha-cell proliferation and glucagon secretion through cell-cycle genes.","evidence":"Triple conditional knockout (Pax6-Cre) mice with physiological, hormone-secretion, and islet gene-expression readouts","pmids":["26021489"],"confidence":"High","gaps":["Whether FOXP4 binds the cell-cycle gene promoters directly not shown","Individual FOXP4 contribution masked by redundancy"]},{"year":2019,"claim":"Identified FOXP4 as a direct driver of EMT in carcinoma by binding and activating Slug and Snail promoters.","evidence":"ChIP/qChIP and luciferase reporter assays with gain/loss-of-function in HCC and breast cancer cells","pmids":["30930991","31040716"],"confidence":"Medium","gaps":["Upstream signals controlling FOXP4 in these tumors not defined","Single-lab evidence per cancer type"]},{"year":2019,"claim":"Extended FOXP combinatorial roles to behavior, showing FoxP4 contributes non-redundantly but partly overlapping with FoxP1/2 to vocal learning.","evidence":"Lentiviral knockdown in zebra finch Area X with quantified song analysis","pmids":["31641053"],"confidence":"Medium","gaps":["Molecular targets underlying song deficits unknown","Mammalian relevance not directly tested"]},{"year":2020,"claim":"Established the disease mechanism: forkhead-domain missense variants cause loss of repressor activity and sometimes mislocalization, defining an autosomal dominant neurodevelopmental disorder.","evidence":"Luciferase repressor and localization assays across patient variants with clinical phenotyping of 8 individuals","pmids":["33110267"],"confidence":"High","gaps":["In vivo neurodevelopmental targets driving the phenotype not identified","Genotype-phenotype correlation across the variant spectrum incomplete"]},{"year":2021,"claim":"Placed FOXP4 in thermogenic control, acting downstream of HSF1 to directly activate UCP1 in adipocytes.","evidence":"ChIP and luciferase assays, gain/loss-of-function in adipocytes, oxygen consumption, and in vivo thermogenic stimulation","pmids":["34384787"],"confidence":"Medium","gaps":["Reconciling activator role here with later repressor role in differentiated beige cells","Full thermogenic target set not mapped"]},{"year":2022,"claim":"Resolved a stage-specific dual role in adipocytes: FOXP4 is required for early beige differentiation but represses the thermogenic program in differentiated beige cells.","evidence":"Beige adipocyte-specific conditional knockouts at progenitor and differentiated stages with cold exposure and gene expression","pmids":["35297993"],"confidence":"Medium","gaps":["Mechanism switching FOXP4 between activator and repressor states unknown","Beige-versus-brown specificity determinants undefined"]},{"year":2022,"claim":"Showed FOXP4 partners with FOXP1 in a complex to maintain the hair follicle stem cell niche, with redundancy revealed only by double knockout.","evidence":"Reciprocal co-immunoprecipitation and single/double conditional knockout mice with niche and apoptosis analysis","pmids":["35759955"],"confidence":"Medium","gaps":["Direct promoter targets (Fgf18, Bmp6) binding not confirmed","Whether FOXP4 acts as activator or repressor at these loci unclear"]},{"year":2023,"claim":"Defined a cell-biological mechanism in cortical development, placing FOXP4 upstream of N-cadherin adherens junctions required for radial migration.","evidence":"In utero shRNA/dominant-negative knockdown with N-cadherin overexpression rescue in mouse neocortex","pmids":["36646976"],"confidence":"Medium","gaps":["Whether FOXP4 directly transcribes N-cadherin not shown","Link to human neurodevelopmental disorder phenotype not directly tested"]},{"year":2023,"claim":"Extended FOXP4's pro-proliferative role to human spermatogonial stem cells, marking and sustaining a stem subset.","evidence":"Conditional inactivation in human SSC lines with scRNA-seq, proliferation, and apoptosis assays","pmids":["36018067"],"confidence":"Medium","gaps":["Direct transcriptional targets in SSCs not identified","In vivo human relevance limited to cell lines"]},{"year":2024,"claim":"Expanded the FOXP4 oncogenic target repertoire across tumor types, linking it directly to Wnt signaling, ferroptosis resistance, stemness, and growth/EMT regulators.","evidence":"ChIP/CUT&Tag, RNA-seq, luciferase, and rescue experiments identifying PTK7, GPX4, SOX12, FBXW7, NDST2, CYP26B1, and MYC across ovarian, colorectal, gastric, thyroid, hepatocellular, and esophageal cancers","pmids":["38740744","40789053","39047223","38293397","39429915","40228145","34590150"],"confidence":"Medium","gaps":["Determinants of activator-versus-repressor choice at different promoters unknown","Each target largely supported by single-lab evidence"]},{"year":2025,"claim":"Demonstrated that FOXP1 and FOXP4 redundantly enforce Treg suppressive identity, jointly binding the Il2ra (CD25) promoter to prevent autoimmunity.","evidence":"Foxp3-Cre single and double conditional knockouts with immune phenotyping, cytokine assays, and Il2ra promoter-binding assays","pmids":["40794436"],"confidence":"High","gaps":["FOXP4-specific (non-redundant) Treg targets not separated","Direct contribution of FOXP4 binding at CD25 versus FOXP1 not isolated"]},{"year":null,"claim":"It remains unresolved what molecular switch determines whether FOXP4 acts as a transcriptional activator or repressor at a given promoter, and how its tissue-specific cofactor partnerships dictate context-dependent outcomes.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of FOXP4 on DNA or in FOXP dimers","Cofactors converting FOXP4 between activation and repression unidentified","Genome-wide endogenous FOXP4 binding landscape across tissues not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,5,6,8,9,17,22,23]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,6,17,19,20,21,23]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[10,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,25]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,5,6,9,17,22,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,12,13,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[15,18,19]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,25]}],"complexes":["FOXP1/FOXP4 complex","FOXP4/FOXP1/FOXP2 dimers"],"partners":["FOXP1","FOXP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IVH2","full_name":"Forkhead box protein P4","aliases":["Fork head-related protein-like A"],"length_aa":680,"mass_kda":73.5,"function":"Transcriptional repressor that represses lung-specific expression","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8IVH2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOXP4","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOXP4","total_profiled":1310},"omim":[{"mim_id":"608924","title":"FORKHEAD BOX P4; FOXP4","url":"https://www.omim.org/entry/608924"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FOXP4"},"hgnc":{"alias_symbol":["FLJ40908"],"prev_symbol":[]},"alphafold":{"accession":"Q8IVH2","domains":[{"cath_id":"-","chopping":"125-157_185-192","consensus_level":"medium","plddt":75.3134,"start":125,"end":192},{"cath_id":"1.10.10.10","chopping":"465-547","consensus_level":"high","plddt":93.0261,"start":465,"end":547}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IVH2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IVH2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IVH2-F1-predicted_aligned_error_v6.png","plddt_mean":58.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOXP4","jax_strain_url":"https://www.jax.org/strain/search?query=FOXP4"},"sequence":{"accession":"Q8IVH2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IVH2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IVH2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IVH2"}},"corpus_meta":[{"pmid":"31209207","id":"PMC_31209207","title":"LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31209207","citation_count":104,"is_preprint":false},{"pmid":"30478938","id":"PMC_30478938","title":"CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30478938","citation_count":97,"is_preprint":false},{"pmid":"31270953","id":"PMC_31270953","title":"Circular RNA circABCC4 as the ceRNA of miR-1182 facilitates prostate cancer progression by promoting FOXP4 expression.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31270953","citation_count":71,"is_preprint":false},{"pmid":"14516685","id":"PMC_14516685","title":"Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/14516685","citation_count":70,"is_preprint":false},{"pmid":"12818433","id":"PMC_12818433","title":"FoxP4, a novel forkhead transcription factor.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12818433","citation_count":66,"is_preprint":false},{"pmid":"34294888","id":"PMC_34294888","title":"Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34294888","citation_count":65,"is_preprint":false},{"pmid":"25755720","id":"PMC_25755720","title":"MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25755720","citation_count":57,"is_preprint":false},{"pmid":"25027557","id":"PMC_25027557","title":"Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization.","date":"2014","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/25027557","citation_count":55,"is_preprint":false},{"pmid":"27704627","id":"PMC_27704627","title":"Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.","date":"2016","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/27704627","citation_count":55,"is_preprint":false},{"pmid":"18561326","id":"PMC_18561326","title":"Expression of Foxp4 in the developing and adult rat forebrain.","date":"2008","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/18561326","citation_count":52,"is_preprint":false},{"pmid":"32256085","id":"PMC_32256085","title":"LncRNA FOXP4-AS1 Is Involved in Cervical Cancer Progression via Regulating miR-136-5p/CBX4 Axis.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32256085","citation_count":49,"is_preprint":false},{"pmid":"30930991","id":"PMC_30930991","title":"Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30930991","citation_count":49,"is_preprint":false},{"pmid":"26021489","id":"PMC_26021489","title":"The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice.","date":"2015","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/26021489","citation_count":48,"is_preprint":false},{"pmid":"29859193","id":"PMC_29859193","title":"FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29859193","citation_count":47,"is_preprint":false},{"pmid":"25994569","id":"PMC_25994569","title":"FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25994569","citation_count":40,"is_preprint":false},{"pmid":"29702064","id":"PMC_29702064","title":"Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316.","date":"2018","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/29702064","citation_count":35,"is_preprint":false},{"pmid":"22662242","id":"PMC_22662242","title":"Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22662242","citation_count":35,"is_preprint":false},{"pmid":"22912696","id":"PMC_22912696","title":"Foxp4 is dispensable for T cell development, but required for robust recall responses.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912696","citation_count":34,"is_preprint":false},{"pmid":"32181485","id":"PMC_32181485","title":"CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32181485","citation_count":34,"is_preprint":false},{"pmid":"33350095","id":"PMC_33350095","title":"Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33350095","citation_count":33,"is_preprint":false},{"pmid":"12617805","id":"PMC_12617805","title":"Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues.","date":"2002","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/12617805","citation_count":33,"is_preprint":false},{"pmid":"25556631","id":"PMC_25556631","title":"Differential coexpression of FoxP1, FoxP2, and FoxP4 in the Zebra Finch (Taeniopygia guttata) song system.","date":"2015","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25556631","citation_count":30,"is_preprint":false},{"pmid":"32159250","id":"PMC_32159250","title":"YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells.","date":"2020","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/32159250","citation_count":29,"is_preprint":false},{"pmid":"20951773","id":"PMC_20951773","title":"Foxp4 is essential in maintenance of Purkinje cell dendritic arborization in the mouse cerebellum.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20951773","citation_count":27,"is_preprint":false},{"pmid":"31641053","id":"PMC_31641053","title":"Differential Song Deficits after Lentivirus-Mediated Knockdown of FoxP1, FoxP2, or FoxP4 in Area X of Juvenile Zebra Finches.","date":"2019","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31641053","citation_count":26,"is_preprint":false},{"pmid":"31040716","id":"PMC_31040716","title":"Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT.","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/31040716","citation_count":25,"is_preprint":false},{"pmid":"33110267","id":"PMC_33110267","title":"Heterozygous variants that disturb the transcriptional repressor activity of FOXP4 cause a developmental disorder with speech/language delays and multiple congenital abnormalities.","date":"2020","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33110267","citation_count":23,"is_preprint":false},{"pmid":"31646567","id":"PMC_31646567","title":"The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31646567","citation_count":21,"is_preprint":false},{"pmid":"34377235","id":"PMC_34377235","title":"CircRPPH1 serves as a sponge for miR-296-5p to enhance progression of breast cancer by regulating FOXP4 expression.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/34377235","citation_count":21,"is_preprint":false},{"pmid":"34765540","id":"PMC_34765540","title":"LncRNA FOXP4-AS1 Promotes Progression of Ewing Sarcoma and Is Associated With Immune Infiltrates.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34765540","citation_count":18,"is_preprint":false},{"pmid":"34970490","id":"PMC_34970490","title":"LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34970490","citation_count":18,"is_preprint":false},{"pmid":"31695417","id":"PMC_31695417","title":"Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31695417","citation_count":18,"is_preprint":false},{"pmid":"32547087","id":"PMC_32547087","title":"LncRNA SNHG16 Promotes the Progression of Laryngeal Squamous Cell Carcinoma by Mediating miR-877-5p/FOXP4 Axis.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32547087","citation_count":18,"is_preprint":false},{"pmid":"38687433","id":"PMC_38687433","title":"FOXP4-AS1 promotes CD8+ T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1.","date":"2024","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/38687433","citation_count":17,"is_preprint":false},{"pmid":"33936279","id":"PMC_33936279","title":"miR-491-5p inhibits the proliferation and migration of A549 cells by FOXP4.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33936279","citation_count":16,"is_preprint":false},{"pmid":"38740744","id":"PMC_38740744","title":"FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38740744","citation_count":15,"is_preprint":false},{"pmid":"31114338","id":"PMC_31114338","title":"LncRNA LOC105372579 promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma via activating miR-4316/FOXP4 signaling.","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/31114338","citation_count":15,"is_preprint":false},{"pmid":"39047223","id":"PMC_39047223","title":"FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/39047223","citation_count":14,"is_preprint":false},{"pmid":"34545456","id":"PMC_34545456","title":"Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2.","date":"2021","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34545456","citation_count":14,"is_preprint":false},{"pmid":"26642711","id":"PMC_26642711","title":"Association of FOXP4 Gene with Prostate Cancer and the Cumulative Effects of rs4714476 and 8q24 in Chinese Men.","date":"2015","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/26642711","citation_count":13,"is_preprint":false},{"pmid":"31911853","id":"PMC_31911853","title":"MiR-3196, a p53-responsive microRNA, functions as a tumor suppressor in hepatocellular carcinoma by targeting FOXP4.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31911853","citation_count":13,"is_preprint":false},{"pmid":"33649850","id":"PMC_33649850","title":"circ‑0000212 promotes cell proliferation of colorectal cancer by sponging miR‑491 and modulating FOXP4 expression.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33649850","citation_count":11,"is_preprint":false},{"pmid":"32436934","id":"PMC_32436934","title":"MicroRNA-4651 represses hepatocellular carcinoma cell growth and facilitates apoptosis via targeting FOXP4.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32436934","citation_count":10,"is_preprint":false},{"pmid":"36018067","id":"PMC_36018067","title":"FOXP4 promotes proliferation of human spermatogonial stem cells.","date":"2023","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/36018067","citation_count":9,"is_preprint":false},{"pmid":"31500519","id":"PMC_31500519","title":"MicroRNA-299-3p/FOXP4 Axis Regulates the Proliferation and Migration of Oral Squamous Cell Carcinoma.","date":"2019","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/31500519","citation_count":9,"is_preprint":false},{"pmid":"33015780","id":"PMC_33015780","title":"Long noncoding RNA LINC00858 promotes the proliferation, migration and invasion of gastric cancer cells via the miR-363-3p/FOXP4 axis.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33015780","citation_count":9,"is_preprint":false},{"pmid":"34590150","id":"PMC_34590150","title":"FOXP4 promotes laryngeal squamous cell carcinoma progression through directly targeting LEF‑1.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34590150","citation_count":8,"is_preprint":false},{"pmid":"35720005","id":"PMC_35720005","title":"FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35720005","citation_count":8,"is_preprint":false},{"pmid":"36961080","id":"PMC_36961080","title":"LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial-mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1.","date":"2023","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/36961080","citation_count":7,"is_preprint":false},{"pmid":"34921595","id":"PMC_34921595","title":"LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis.","date":"2022","source":"Journal of tissue engineering and regenerative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34921595","citation_count":7,"is_preprint":false},{"pmid":"35838233","id":"PMC_35838233","title":"FOXP4 inhibits squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35838233","citation_count":7,"is_preprint":false},{"pmid":"39539976","id":"PMC_39539976","title":"Emerging roles of long non-coding RNA FOXP4-AS1 in human cancers: From molecular biology to clinical application.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39539976","citation_count":6,"is_preprint":false},{"pmid":"35642665","id":"PMC_35642665","title":"Downregulation of microRNA‑423‑5p suppresses TGF‑β1‑induced EMT by targeting FOXP4 in airway fibrosis.","date":"2022","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/35642665","citation_count":6,"is_preprint":false},{"pmid":"34500373","id":"PMC_34500373","title":"LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.","date":"2021","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/34500373","citation_count":6,"is_preprint":false},{"pmid":"34384787","id":"PMC_34384787","title":"The forkhead box transcription factor FoxP4 regulates thermogenic programs in adipocytes.","date":"2021","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/34384787","citation_count":5,"is_preprint":false},{"pmid":"38994097","id":"PMC_38994097","title":"Prediction and assessment of deleterious and disease causing nonsynonymous single nucleotide polymorphisms (nsSNPs) in human FOXP4 gene: An in - silico study.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38994097","citation_count":4,"is_preprint":false},{"pmid":"35759955","id":"PMC_35759955","title":"Foxp1 and Foxp4 Deletion Causes the Loss of Follicle Stem Cell Niche and Cyclic Hair Shedding by Inducing Inner Bulge Cell Apoptosis.","date":"2022","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/35759955","citation_count":4,"is_preprint":false},{"pmid":"30481065","id":"PMC_30481065","title":"Retracted: Long Noncoding RNA SOX2OT Accelerates the Carcinogenesis of Wilms' Tumor Through ceRNA Through miR-363/FOXP4 Axis.","date":"2018","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30481065","citation_count":4,"is_preprint":false},{"pmid":"40794436","id":"PMC_40794436","title":"Normal Treg homeostasis and suppressive function require both FOXP1 and FOXP4.","date":"2025","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/40794436","citation_count":3,"is_preprint":false},{"pmid":"37114256","id":"PMC_37114256","title":"The FOXP4-AS1/miR-3130-3p/SP4 feedback loop is associated with prostate cancer.","date":"2022","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/37114256","citation_count":3,"is_preprint":false},{"pmid":"38890503","id":"PMC_38890503","title":"Androgen-responsive FOXP4 is a target for endometrial carcinoma.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38890503","citation_count":3,"is_preprint":false},{"pmid":"39429915","id":"PMC_39429915","title":"Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2.","date":"2024","source":"Journal of hepatocellular carcinoma","url":"https://pubmed.ncbi.nlm.nih.gov/39429915","citation_count":3,"is_preprint":false},{"pmid":"38429664","id":"PMC_38429664","title":"Polymorphisms of IFN signaling genes and FOXP4 influence the severity of COVID-19.","date":"2024","source":"BMC infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38429664","citation_count":3,"is_preprint":false},{"pmid":"39513116","id":"PMC_39513116","title":"METTL14 Induced N6-Methyladenosine Modification of FOXP4 mRNA in HBV-HCC.","date":"2024","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39513116","citation_count":3,"is_preprint":false},{"pmid":"36646976","id":"PMC_36646976","title":"Inhibition of Foxp4 Disrupts Cadherin-based Adhesion of Radial Glial Cells, Leading to Abnormal Differentiation and Migration of Cortical Neurons in Mice.","date":"2023","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/36646976","citation_count":3,"is_preprint":false},{"pmid":"40789053","id":"PMC_40789053","title":"Patients-Derived Organoids Sequencing-based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40789053","citation_count":2,"is_preprint":false},{"pmid":"38293397","id":"PMC_38293397","title":"Transcription factor FOXP4 inversely governs tumor suppressor genes and contributes to thyroid cancer progression.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38293397","citation_count":2,"is_preprint":false},{"pmid":"38512300","id":"PMC_38512300","title":"Participation of Long Noncoding RNA FOXP4-AS1 in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing DUSP5.","date":"2024","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/38512300","citation_count":2,"is_preprint":false},{"pmid":"35297993","id":"PMC_35297993","title":"FOXP4 differentially controls cold-induced beige adipocyte differentiation and thermogenesis.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35297993","citation_count":2,"is_preprint":false},{"pmid":"36763305","id":"PMC_36763305","title":"Hsa_circ_0017956 Acts as miR-758-3p Sponge to Facilitate the Progression of Non-small-Cell Lung Cancer by Regulating FOXP4 Expression.","date":"2023","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/36763305","citation_count":1,"is_preprint":false},{"pmid":"41486276","id":"PMC_41486276","title":"LncRNA FOXP4-AS1 facilitates colorectal cancer invasion and migration by enhancing USP7 interaction with ZEB1.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41486276","citation_count":1,"is_preprint":false},{"pmid":"36752821","id":"PMC_36752821","title":"The essential role of forkhead box P4 (FOXP4) in thyroid cancer: a study related to The Cancer Genome Atlas and experimental data.","date":"2023","source":"Endocrine connections","url":"https://pubmed.ncbi.nlm.nih.gov/36752821","citation_count":1,"is_preprint":false},{"pmid":"41133246","id":"PMC_41133246","title":"LINC00917 Promotes Bone Metastasis of Breast Cancer by Targeting the miR-491-5p/FOXP4 Axis.","date":"2025","source":"Breast cancer (Dove Medical Press)","url":"https://pubmed.ncbi.nlm.nih.gov/41133246","citation_count":1,"is_preprint":false},{"pmid":"36313704","id":"PMC_36313704","title":"Corrigendum: LncRNA FOXP4-AS1 promotes the progression of esophageal squamous cell carcinoma by interacting with MLL2/H3K4me3 to upregulate FOXP4.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36313704","citation_count":1,"is_preprint":false},{"pmid":"40228145","id":"PMC_40228145","title":"Cis-Regulatory Alterations in FOXP4 Modulate Esophageal Cancer Susceptibility Induced by Chronic Alcohol Exposure.","date":"2025","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/40228145","citation_count":0,"is_preprint":false},{"pmid":"40637512","id":"PMC_40637512","title":"FOXP4 Variants Are Associated With Plateau Iris and Angle Closure Glaucoma.","date":"2025","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/40637512","citation_count":0,"is_preprint":false},{"pmid":"42066828","id":"PMC_42066828","title":"FOXP4-AS1 suppresses papillary thyroid carcinoma progression by binding to Lactate Dehydrogenase A and suppressing its expression, with implications for metabolic-targeted therapy.","date":"2026","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/42066828","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.25.650520","title":"Structural insights into FOXP2 multimerization and interactions from AlphaFold3 modeling","date":"2025-04-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.25.650520","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.07.622485","title":"<i>FOXP</i>  Genes Regulate Purkinje Cell Diversity in Cerebellar Development and Evolution","date":"2024-11-07","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.07.622485","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.13.25322223","title":"Integrative Genome-Wide Association Studies of COVID-19 Susceptibility and Hospitalization Reveal Risk Loci for Long COVID","date":"2025-02-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.13.25322223","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42403,"output_tokens":6679,"usd":0.113697,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15762,"output_tokens":4662,"usd":0.09768,"stage2_stop_reason":"end_turn"},"total_usd":0.211377,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"FOXP4 is a member of the Foxp subfamily of winged-helix (forkhead) transcription factors, encoding a 685-amino-acid protein similar to FOXP1 and FOXP2, expressed primarily in pulmonary epithelium (proximal and distal airway), neural tissues, and gut epithelial cells during embryonic development, as determined by immunohistochemical analysis with specific polyclonal antisera.\",\n      \"method\": \"Immunohistochemistry with specific polyclonal antisera; in situ hybridization; cDNA characterization\",\n      \"journal\": \"Mechanisms of development / Gene expression patterns\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein localization by IHC with specific antisera and parallel in situ hybridization, replicated across two publications from same group\",\n      \"pmids\": [\"14516685\", \"12617805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOXP4 forms homo- and heterodimers with FOXP1 and FOXP2, and specific combinations of FOXP1/2/4 dimers differentially regulate transcription of known FOXP2 target genes (including CER1, SFRP4, WISP2, PRICKLE1, NCOR2, SNW1, NEUROD2, PAX3, EFNB3, and SLIT1) involved in early neuronal development, as shown by stable transfection of open-reading frames into HEK293 cells and quantitative real-time PCR.\",\n      \"method\": \"Stable transfection of FOXP1/2/4 ORFs in HEK293 cells; qRT-PCR of target gene expression\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — cell-based overexpression with qRT-PCR readout, single lab, single method but covers multiple targets and dimer combinations\",\n      \"pmids\": [\"25027557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Foxp4 is expressed specifically in migrating and mature Purkinje cells of the cerebellum and is required for the maintenance (but not initiation) of Purkinje cell dendritic arborization; siRNA-mediated knockdown at postnatal day 10 in organotypic cerebellar slice cultures caused highly impaired dendritic arbor organization and loss of associated Bergmann glial fiber radial alignment, without inducing apoptosis.\",\n      \"method\": \"siRNA knockdown in organotypic cerebellar slice culture; morphological analysis of dendritic arbors\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in organotypic tissue model with defined cellular phenotype, single lab\",\n      \"pmids\": [\"20951773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Foxp4 is expressed in thymocytes and peripheral CD4+ and CD8+ T cells, increases following T cell activation, and is dispensable for T cell development, Foxp3+ Treg generation, and in vitro proliferative/effector responses; however, Foxp4-deficient CD4 T cells show reduced effector cytokine production during antigen-specific recall responses in vivo (Toxoplasma gondii and LCMV infection models), as assessed by CD4Cre-mediated conditional knockout.\",\n      \"method\": \"CD4Cre conditional knockout; flow cytometry; in vivo infection challenge with T. gondii and LCMV; cytokine measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean conditional KO with defined in vivo phenotypic readout, single lab, multiple infection models\",\n      \"pmids\": [\"22912696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Combined conditional knockout of FOXP1, FOXP2, and FOXP4 (but not individual knockouts) in pancreatic islet endocrine cells (using Pax6-Cre) causes hypoglycemia and hypoglucagonemia due to reduced alpha cell mass and impaired glucagon secretion; this is mediated through effects on cell cycle mediators (decreased Ccna2, Ccnb1, Ccnd2; increased Cdkn1a), while beta cell insulin secretion remains intact.\",\n      \"method\": \"Triple conditional knockout (Pax6-Cre) mice; glucose tolerance testing; radioimmunoassay; immunohistochemistry; gene expression in isolated islets; glucose-stimulated hormone secretion assays\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — well-controlled genetic loss-of-function with multiple orthogonal physiological and molecular readouts, epistasis analysis with single and compound KOs\",\n      \"pmids\": [\"26021489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FOXP4 transcriptionally regulates Slug (SNAI2), an EMT-associated transcription factor, to promote EMT in hepatocellular carcinoma cells; this was established by ChIP, qChIP, and luciferase reporter assays showing FOXP4 binding to the Slug promoter, and gain/loss-of-function experiments demonstrating FOXP4 controls migration and invasion through this mechanism.\",\n      \"method\": \"ChIP and qChIP assays; luciferase reporter assay; gain- and loss-of-function experiments in HCC cell lines\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding confirmed by ChIP plus functional validation by luciferase, single lab\",\n      \"pmids\": [\"30930991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FOXP4 transcriptionally activates Snail (SNAI1) in breast cancer cells by binding to the Snail promoter (confirmed by ChIP, qChIP, and dual luciferase reporter assays), promoting EMT; overexpression of Snail partially rescued the inhibitory effect of FOXP4 knockdown on migration and invasion.\",\n      \"method\": \"ChIP assay; dual luciferase reporter assay; gain- and loss-of-function experiments\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter binding confirmed by ChIP plus luciferase, single lab\",\n      \"pmids\": [\"31040716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Lentiviral knockdown of FoxP4 in Area X (striatal song nucleus) of juvenile male zebra finches impaired vocal production learning, with song deficits partly overlapping but distinct from those caused by FoxP1 or FoxP2 knockdown, indicating non-redundant but partially shared roles of FoxP1/2/4 in Area X-dependent vocal learning.\",\n      \"method\": \"Lentivirus-mediated knockdown in Area X of juvenile zebra finches; song analysis (spectral and temporal features); comparison across FoxP1/2/4 knockdown groups\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vivo loss-of-function with quantified behavioral readout, multiple FoxP comparisons, single lab\",\n      \"pmids\": [\"31641053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Heterozygous missense variants in the FOXP4 forkhead box DNA-binding domain cause loss of transcriptional repressor activity (demonstrated by luciferase assays) and in some cases aberrant subcellular localization, leading to an autosomal dominant neurodevelopmental disorder with speech/language delays, growth abnormalities, congenital diaphragmatic hernia, cervical spine abnormalities, and ptosis.\",\n      \"method\": \"Luciferase transcriptional repressor assays; subcellular localization assays; clinical phenotyping of 8 individuals with de novo FOXP4 variants\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal functional assays (luciferase + localization) across multiple independent patient variants, establishes loss-of-function mechanism\",\n      \"pmids\": [\"33110267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FOXP4 directly activates UCP1 transcription in thermogenic adipocytes, as demonstrated by chromatin immunoprecipitation and luciferase assays; FoxP4 is induced by heat shock factor protein 1 (HSF1) via a heat shock response element in the FoxP4 proximal promoter, and gain/loss-of-function studies show FoxP4 regulates multiple brown and beige fat genes and affects oxygen consumption in isolated adipocytes.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); luciferase reporter assay; gain- and loss-of-function in adipocytes; oxygen consumption assay; in vivo thermogenic stimulation\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct ChIP and luciferase evidence for UCP1 regulation and HSF1-mediated induction, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"34384787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FOXP4 deficiency in beige adipocyte progenitors impairs early beige cell differentiation, whereas ablation of Foxp4 in differentiated adipocytes potentiates thermogenesis capacity upon cold exposure by de-repressing the thermogenic program; this effect is specific to beige adipocytes and not brown adipocytes, establishing FOXP4 as a transcriptional repressor of the beige thermogenic program in differentiated cells.\",\n      \"method\": \"Beige adipocyte-specific conditional knockout mice; cold exposure experiments; gene expression analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO mouse models at two different cell stages with defined functional phenotype, single lab\",\n      \"pmids\": [\"35297993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FOXP4 promotes proliferation and inhibits squamous differentiation of atypical cervical cells via an ELF3-dependent pathway; FOXP4 knockdown in W12 (HPV16+) cells attenuated proliferation and induced squamous differentiation in monolayer and organotypic raft cultures through regulation of ELF3.\",\n      \"method\": \"FOXP4 siRNA knockdown in W12 cells; monolayer and organotypic raft culture; proliferation assays; gene expression analysis; ELF3 pathway analysis\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in two culture systems with defined differentiation phenotype and pathway placement via ELF3, single lab\",\n      \"pmids\": [\"35838233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FOXP1 and FOXP4 form a complex in vivo in hair follicle cells; combined (but not individual) conditional knockout of Foxp1/4 in hair follicles causes additive defects including precocious HFSC activation, hair cycling acceleration, hair loss, downregulation of Fgf18 and Bmp6 in bulge cells, and apoptosis of K6+ inner bulge cells (the stem cell niche), leading to destruction of the niche.\",\n      \"method\": \"Co-immunoprecipitation (complex formation in vitro and in vivo); hair follicle-specific conditional knockout mice (single and double KO); immunofluorescence; apoptosis assays; gene expression\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal complex formation plus genetic epistasis via double KO with defined niche phenotype, single lab\",\n      \"pmids\": [\"35759955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FOXP4 knockdown or dominant-negative inhibition in the mouse neocortex abolishes apical condensation of N-cadherin in radial glial cells (RGCs), disrupts adherens junction integrity in the ventricular zone, impedes radial migration of cortical neurons, and causes ectopic neurogenesis; N-cadherin overexpression in RGCs rescues the migration and differentiation defects, placing FOXP4 upstream of N-cadherin-based adherens junctions in cortical development.\",\n      \"method\": \"In utero shRNA knockdown and dominant-negative inhibition; N-cadherin overexpression rescue; immunofluorescence; cortical neuron migration analysis in mice\",\n      \"journal\": \"Neuroscience bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with genetic rescue experiment establishing epistatic relationship, single lab\",\n      \"pmids\": [\"36646976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FOXP4 promotes proliferation of human spermatogonial stem cells (SSCs); conditional inactivation of FOXP4 in human SSC lines suppressed proliferation and significantly activated apoptosis, and FOXP4 expression was found to specifically mark a subset of spermatogonia with stem cell potential.\",\n      \"method\": \"Conditional inactivation in human SSC lines; single-cell RNA sequencing analysis; proliferation and apoptosis assays\",\n      \"journal\": \"Asian journal of andrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in human SSC lines with defined proliferation/apoptosis phenotype, supported by single-cell expression data, single lab\",\n      \"pmids\": [\"36018067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXP4 directly induces PTK7 (a Wnt co-receptor) transcription in ovarian cancer, thereby activating the Wnt/β-catenin signaling pathway and promoting malignant phenotype; RNA sequencing in FOXP4-deficient cells identified PTK7 as a downstream target, and restoration of PTK7 reversed the effects of FOXP4 loss.\",\n      \"method\": \"RNA sequencing in FOXP4-deficient cells; ChIP or functional promoter assays (inferred from 'directly induces'); PTK7 rescue experiments; Wnt pathway activity assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-seq plus genetic rescue establishing pathway hierarchy, single lab; direct binding evidence implied but not explicitly detailed in abstract\",\n      \"pmids\": [\"38740744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXP4 is a direct transcriptional target of YAP1 in gastric cancer; FOXP4 upregulation by YAP1 maintains cancer stemness by transcriptionally activating SOX12; FOXP4 loss impairs spheroid formation and stemness marker expression, while a small-molecule screen identified 42-(2-tetrazolyl) rapamycin as a FOXP4 inhibitor.\",\n      \"method\": \"RNA sequencing; functional loss-of-function (spheroid, stemness markers); small-molecule inhibitor screen; ChIP or transcriptional assays for YAP1→FOXP4 and FOXP4→SOX12; in vivo xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-seq plus functional and pharmacological validation, multiple downstream targets, single lab\",\n      \"pmids\": [\"39047223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXP4 promotes radioresistance in colorectal cancer by transcriptionally activating GPX4 (glutathione peroxidase 4) via binding to the GPX4 promoter through its forkhead domain, thereby suppressing ferroptosis; doxorubicin promotes FOXP4 ubiquitination and degradation, reducing GPX4 expression and increasing radiosensitivity.\",\n      \"method\": \"Patient-derived organoids (PDOs); transcriptome analysis; ChIP/CUT&Tag for FOXP4 binding to GPX4 promoter; ubiquitination assay; clonogenic and xenograft assays\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding by CUT&Tag plus functional ferroptosis and ubiquitination assays, single lab with PDO model\",\n      \"pmids\": [\"40789053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FOXP4 transcriptionally activates β-catenin (CTNNB1) expression in esophageal squamous cell carcinoma cells, thereby promoting Wnt/β-catenin signaling and malignant progression; this was established by luciferase reporter assay showing FOXP4 drives β-catenin transcription.\",\n      \"method\": \"Luciferase reporter assay; shRNA knockdown; gene expression analysis; RIP and ChIP (for FOXP4-AS1 mechanism upstream)\",\n      \"journal\": \"Frontiers in oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — luciferase assay for FOXP4→β-catenin, single lab, single method for this specific mechanistic claim\",\n      \"pmids\": [\"34970490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FOXP4 directly binds the promoter of LEF-1 and activates Wnt signaling in laryngeal squamous cell carcinoma, as confirmed by chromatin immunoprecipitation and luciferase reporter assays; FOXP4 also participates in EMT regulation in this cancer type.\",\n      \"method\": \"ChIP assay; luciferase reporter assay; gain- and loss-of-function experiments; microarray for differential transcript identification\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter binding confirmed by ChIP plus luciferase, single lab\",\n      \"pmids\": [\"34590150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXP4 transcriptionally represses FBXW7 (a tumor suppressor) in thyroid cancer cells; FOXP4 protein binding to the FBXW7 promoter was confirmed by ChIP assay, and FBXW7 overexpression reversed the effects of FOXP4-driven proliferation, migration, and EMT.\",\n      \"method\": \"ChIP assay; luciferase reporter; gain- and loss-of-function; xenograft\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter binding by ChIP with functional rescue experiment, single lab\",\n      \"pmids\": [\"38293397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXP4 transcriptionally activates NDST2 in hepatocellular carcinoma cells after incomplete thermal ablation (heat stress), as validated by CUT&Tag experiments showing FOXP4 binding to NDST2 regulatory regions; suppression of FOXP4 reduced NDST2 expression and weakened cancer cell progression.\",\n      \"method\": \"CUT&Tag; qRT-PCR; Western blotting; CCK-8, scratch, Transwell assays\",\n      \"journal\": \"Journal of hepatocellular carcinoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromatin binding by CUT&Tag with functional loss-of-function, single lab\",\n      \"pmids\": [\"39429915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Combined but not individual deficiency of FOXP1 and FOXP4 in FOXP3+ committed Tregs causes lymphoproliferation, inflammation, autoimmunity, and early lethality; loss of both proteins results in an activated/effector phenotype with compromised Treg suppressive function, enhanced germinal center response, and proinflammatory cytokine production; FOXP1 and FOXP4 both bind to Il2ra (CD25) promoter regions to regulate CD25 expression, as demonstrated by promoter-binding assays.\",\n      \"method\": \"Foxp3-Cre conditional knockout of Foxp1, Foxp4, or both; flow cytometry; cytokine assays; promoter-binding assays for Il2ra; immune phenotyping\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous triple genetic comparison (single and double KO) with multiple orthogonal functional readouts and direct promoter binding evidence\",\n      \"pmids\": [\"40794436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"An enhancer variant (rs10223516) in FOXP4 modulates FOXP4 expression through long-range chromatin interaction; the T allele shows higher enhancer activity; upregulated FOXP4 promotes ESCC development in vivo; ChIP-seq and RNA-seq revealed FOXP4 transcriptionally activates CYP26B1 and MYC in ESCC cells.\",\n      \"method\": \"Three-stage case-control GWAS; functional enhancer assay; in vivo ESCC model; ChIP-seq; RNA-seq\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enhancer activity assay plus ChIP-seq for direct transcriptional targets, supported by large genetic study, single lab\",\n      \"pmids\": [\"40228145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL14-induced N6-methyladenosine (m6A) modification of FOXP4 mRNA in HBV-infected hepatocellular carcinoma cells enhances FOXP4 mRNA stability and increases FOXP4 mRNA levels; HBV gene expression activates the PI3K/AKT pathway via modulation of FOXP4 mRNA stability.\",\n      \"method\": \"m6A modification analysis; mRNA stability assays; PI3K/AKT pathway analysis; HBV infection model\",\n      \"journal\": \"Journal of Cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mRNA modification and stability assays described in abstract without full mechanistic detail, single lab, single study\",\n      \"pmids\": [\"39513116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOXP4 is highly expressed in anterior segment structures relevant to the drainage angle (periocular mesenchyme, iris, ciliary body, cornea) in embryonic mouse eyes; a FOXP4 missense variant (p.Q478R) in the forkhead domain acts as a hypomorphic allele retaining transcriptional activity but frequently mislocalizing to cytosolic aggregates, suggesting protein instability underlies pathogenicity in angle closure glaucoma.\",\n      \"method\": \"Exome sequencing; immunostaining in embryonic mouse eyes; YFP-tagged mutant/WT protein expression in HEK-293T and ARPE-19 cells for nuclear localization; SRPX2-luciferase reporter for transcriptional activity\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell-based functional assays (localization + transcriptional reporter) plus in vivo expression data, single lab\",\n      \"pmids\": [\"40637512\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FOXP4 is a forkhead box transcription factor that functions as a transcriptional activator or repressor depending on cellular context; it homo- and heterodimerizes with FOXP1 and FOXP2 to differentially regulate target gene expression, directly binds promoters of downstream targets including UCP1, GPX4, Slug/Snail, LEF-1, PTK7, SOX12, FBXW7, NDST2, CYP26B1, MYC, and CD25 (Il2ra), and plays essential developmental roles in lung/gut epithelium, Purkinje cell dendritic maintenance, cortical neuron migration (via N-cadherin adherens junctions), alpha cell proliferation and glucagon secretion, thermogenic adipocyte differentiation and activation, hair follicle stem cell niche maintenance (redundantly with FOXP1), and T cell cytokine recall responses; heterozygous loss-of-function variants in its forkhead DNA-binding domain cause an autosomal dominant neurodevelopmental disorder with speech/language delays and congenital abnormalities.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FOXP4 is a forkhead/winged-helix transcription factor of the FOXP subfamily that acts as a context-dependent activator or repressor to control epithelial, neuronal, immune, metabolic, and stem-cell programs during development [#0, #1]. It assembles into homo- and heterodimers with FOXP1 and FOXP2, and distinct dimer combinations differentially tune shared neuronal target genes, establishing combinatorial FOXP coding as a core regulatory logic [#1]. This combinatorial principle recurs across tissues through genetic redundancy: only compound loss of FOXP1/2/4 in pancreatic islet endocrine cells reduces alpha-cell mass and glucagon secretion via cell-cycle mediators [#4], compound FOXP1/4 loss in hair follicles destroys the stem-cell niche [#12], and combined FOXP1/4 deletion in Tregs causes autoimmunity, with both factors binding the Il2ra (CD25) promoter [#22]. FOXP4 directly binds target promoters through its forkhead DNA-binding domain to drive distinct programs: it activates the thermogenic gene UCP1 in adipocytes downstream of HSF1 while acting as a repressor of the beige thermogenic program in differentiated cells [#9, #10], and it controls cortical neuron migration by maintaining N-cadherin-based adherens junctions in radial glia [#13]. In cancer it functions as a pro-malignant transcription factor, directly regulating EMT effectors Slug and Snail, Wnt-pathway components LEF-1 and PTK7, and additional targets including GPX4 (suppressing ferroptosis), SOX12, FBXW7, NDST2, CYP26B1, and MYC [#5, #6, #15, #17]. Heterozygous missense variants in the FOXP4 forkhead domain abolish transcriptional repressor activity and can mislocalize the protein, causing an autosomal dominant neurodevelopmental disorder with speech/language delay and congenital abnormalities [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing FOXP4 as a forkhead transcription factor and mapping its developmental expression defined where in the embryo it might act.\",\n      \"evidence\": \"cDNA characterization, IHC with specific antisera, and in situ hybridization across embryonic tissues\",\n      \"pmids\": [\"14516685\", \"12617805\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct target genes identified at this stage\", \"No functional loss-of-function data\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed FOXP4 has a tissue-specific maintenance role, being required to sustain Purkinje cell dendritic arborization rather than to initiate it.\",\n      \"evidence\": \"siRNA knockdown in organotypic cerebellar slice culture with dendritic morphology analysis\",\n      \"pmids\": [\"20951773\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets in Purkinje cells not identified\", \"Mechanism linking FOXP4 to Bergmann glial alignment unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined a non-essential but modulatory immune role, with FOXP4 dispensable for T cell development but required for full effector cytokine recall responses.\",\n      \"evidence\": \"CD4Cre conditional knockout with in vivo T. gondii and LCMV challenge and cytokine measurement\",\n      \"pmids\": [\"22912696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Target genes controlling cytokine recall not identified\", \"Possible redundancy with other FOXPs not tested here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established the combinatorial logic of FOXP regulation by showing FOXP4 dimerizes with FOXP1/2 and that specific dimers differentially regulate shared targets.\",\n      \"evidence\": \"Stable transfection of FOXP1/2/4 ORFs in HEK293 cells with qRT-PCR of target genes\",\n      \"pmids\": [\"25027557\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression system may not reflect endogenous stoichiometry\", \"Direct DNA binding by FOXP4 not shown in this study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated functional redundancy among FOXP1/2/4 in vivo, where only compound deletion impairs alpha-cell proliferation and glucagon secretion through cell-cycle genes.\",\n      \"evidence\": \"Triple conditional knockout (Pax6-Cre) mice with physiological, hormone-secretion, and islet gene-expression readouts\",\n      \"pmids\": [\"26021489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FOXP4 binds the cell-cycle gene promoters directly not shown\", \"Individual FOXP4 contribution masked by redundancy\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified FOXP4 as a direct driver of EMT in carcinoma by binding and activating Slug and Snail promoters.\",\n      \"evidence\": \"ChIP/qChIP and luciferase reporter assays with gain/loss-of-function in HCC and breast cancer cells\",\n      \"pmids\": [\"30930991\", \"31040716\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream signals controlling FOXP4 in these tumors not defined\", \"Single-lab evidence per cancer type\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended FOXP combinatorial roles to behavior, showing FoxP4 contributes non-redundantly but partly overlapping with FoxP1/2 to vocal learning.\",\n      \"evidence\": \"Lentiviral knockdown in zebra finch Area X with quantified song analysis\",\n      \"pmids\": [\"31641053\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular targets underlying song deficits unknown\", \"Mammalian relevance not directly tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established the disease mechanism: forkhead-domain missense variants cause loss of repressor activity and sometimes mislocalization, defining an autosomal dominant neurodevelopmental disorder.\",\n      \"evidence\": \"Luciferase repressor and localization assays across patient variants with clinical phenotyping of 8 individuals\",\n      \"pmids\": [\"33110267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo neurodevelopmental targets driving the phenotype not identified\", \"Genotype-phenotype correlation across the variant spectrum incomplete\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed FOXP4 in thermogenic control, acting downstream of HSF1 to directly activate UCP1 in adipocytes.\",\n      \"evidence\": \"ChIP and luciferase assays, gain/loss-of-function in adipocytes, oxygen consumption, and in vivo thermogenic stimulation\",\n      \"pmids\": [\"34384787\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciling activator role here with later repressor role in differentiated beige cells\", \"Full thermogenic target set not mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Resolved a stage-specific dual role in adipocytes: FOXP4 is required for early beige differentiation but represses the thermogenic program in differentiated beige cells.\",\n      \"evidence\": \"Beige adipocyte-specific conditional knockouts at progenitor and differentiated stages with cold exposure and gene expression\",\n      \"pmids\": [\"35297993\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism switching FOXP4 between activator and repressor states unknown\", \"Beige-versus-brown specificity determinants undefined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed FOXP4 partners with FOXP1 in a complex to maintain the hair follicle stem cell niche, with redundancy revealed only by double knockout.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation and single/double conditional knockout mice with niche and apoptosis analysis\",\n      \"pmids\": [\"35759955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct promoter targets (Fgf18, Bmp6) binding not confirmed\", \"Whether FOXP4 acts as activator or repressor at these loci unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined a cell-biological mechanism in cortical development, placing FOXP4 upstream of N-cadherin adherens junctions required for radial migration.\",\n      \"evidence\": \"In utero shRNA/dominant-negative knockdown with N-cadherin overexpression rescue in mouse neocortex\",\n      \"pmids\": [\"36646976\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FOXP4 directly transcribes N-cadherin not shown\", \"Link to human neurodevelopmental disorder phenotype not directly tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended FOXP4's pro-proliferative role to human spermatogonial stem cells, marking and sustaining a stem subset.\",\n      \"evidence\": \"Conditional inactivation in human SSC lines with scRNA-seq, proliferation, and apoptosis assays\",\n      \"pmids\": [\"36018067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional targets in SSCs not identified\", \"In vivo human relevance limited to cell lines\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanded the FOXP4 oncogenic target repertoire across tumor types, linking it directly to Wnt signaling, ferroptosis resistance, stemness, and growth/EMT regulators.\",\n      \"evidence\": \"ChIP/CUT&Tag, RNA-seq, luciferase, and rescue experiments identifying PTK7, GPX4, SOX12, FBXW7, NDST2, CYP26B1, and MYC across ovarian, colorectal, gastric, thyroid, hepatocellular, and esophageal cancers\",\n      \"pmids\": [\"38740744\", \"40789053\", \"39047223\", \"38293397\", \"39429915\", \"40228145\", \"34590150\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Determinants of activator-versus-repressor choice at different promoters unknown\", \"Each target largely supported by single-lab evidence\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated that FOXP1 and FOXP4 redundantly enforce Treg suppressive identity, jointly binding the Il2ra (CD25) promoter to prevent autoimmunity.\",\n      \"evidence\": \"Foxp3-Cre single and double conditional knockouts with immune phenotyping, cytokine assays, and Il2ra promoter-binding assays\",\n      \"pmids\": [\"40794436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FOXP4-specific (non-redundant) Treg targets not separated\", \"Direct contribution of FOXP4 binding at CD25 versus FOXP1 not isolated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved what molecular switch determines whether FOXP4 acts as a transcriptional activator or repressor at a given promoter, and how its tissue-specific cofactor partnerships dictate context-dependent outcomes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of FOXP4 on DNA or in FOXP dimers\", \"Cofactors converting FOXP4 between activation and repression unidentified\", \"Genome-wide endogenous FOXP4 binding landscape across tissues not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 5, 6, 8, 9, 17, 22, 23]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 6, 17, 19, 20, 21, 23]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [10, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 5, 6, 9, 17, 22, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 12, 13, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [15, 18, 19]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 25]}\n    ],\n    \"complexes\": [\n      \"FOXP1/FOXP4 complex\",\n      \"FOXP4/FOXP1/FOXP2 dimers\"\n    ],\n    \"partners\": [\n      \"FOXP1\",\n      \"FOXP2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}